ARTHRITIS TREATMENT News, Sports, Shopping, Travel information

Arthritis Treatment
Find: Arthritis Treatment. Review & Compare!
www.findstuff.com

Update 2-biogen Discontinues Experimental Arthritis Drug - Reuters
los angeles, oct 9 (reuters) - biogen idec inc (biib.o: quote , profile , research , stock buzz ) said on thursday it will discontinue development of baminercept as a treatment for rheumatoid arthritis after the experimental drug failed to prove ...
www.reuters.com

Arthritis Drug Boosts Heart Disease Risk, Long-term Study Confirms
the arthritis drug vioxx nearly doubled the risk of heart attack and stroke compared to no treatment at all, according to a long-term follow-up study released tuesday.
news.yahoo.com

Lexicon To Present Clinical Data For Lx2931, An Investigational New Drug For Rheumatoid Arthritis
the woodlands, texas, oct. 14, 2008 -- lexicon pharmaceuticals, inc. , a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be presenting initial phase 1 clinical trial results for lx2931, an orally-delivered, small molecule drug candidate for the treatment of rheumatoid arthritis and other autoimmune ...
biz.yahoo.com

Rheumatoid Arthritis: Treatment Should Consider Patients' Perspective - Pharmiweb
current treatments for rheumatoid arthritis (ra) are failing to control patients' pain adequately, and health care professionals are not fully addressing patients' concerns, new research suggests. at the recent annual congress of rheumatology meeting ...
www.pharmiweb.com

Genentech's 3rd-quarter Profit Rises 6.7 Percent On Cancer Treatment ... - Minneapolis Star Tribune
new york - genentech inc.'s third-quarter profit rose 6.7 percent on rising sales of key cancer drugs, the biotechnology company said tuesday, matching wall street's profit forecasts. the company lowered the top end of its expected outlook for the ...
www.startribune.com

Arthritis Drug Boosts Heart Disease Risk, Long-term Study Confirms
a bottle of the arthritis drug vioxx ia seen in 2004 in new york city. the arthritis drug vioxx nearly doubled the risk of heart attack and stroke compared to no treatment at all, according to a long-term follow-up study released tuesday.
www.todayonline.com

Safety Fears Over Arthritis Drugs
further fears about the safety of some pain-killing arthritis drugs have been raised after new evidence emerged of life-threatening risks associated with one of the medicines.
www.gazetteseries.co.uk

Johnson & Johnson 3q Profit Rises, Tops Views - Houston Chronicle
trenton, n.j. — health care giant johnson & johnson on tuesday posted a 30 percent jump in third-quarter profit and beat wall street expectations, mainly because the year-ago results were weighed down by a $745 million restructuring charge. higher ...
www.chron.com

Safety Fears Over Arthritis Drugs - Guardian Unlimited
further fears about the safety of some pain-killing arthritis drugs have been raised after new evidence emerged of life-threatening risks associated with one of the medicines. a worldwide study involving 2,000 patients found rofecoxib "substantially ...
www.guardian.co.uk

Access To Psychological Support And Self-management Courses Could Ease The Emotional Burden Of Arthritis/rheumatism, ...
an online survey for world arthritis day (wad), completed by over 3,600* respondents revealed that access to psychological support and self-management courses could help people with arthritis/rheumatism cope more effectively with their condition and achieve better quality of life.
www.medicalnewstoday.com

Hiranandani Hospital Organises Dance Competition On World Arthritis Day
scores of middle-aged and senior citizens afflicted by arthritis took centrestage for a dance competition - joints in motion - organized by dr l h hiranandani hospital on october 11 at powai's olympia building, hiranandani gardens.
www.pharmabiz.com

Genentech 3q Profit Rises, Meets Forecast - Cbs News
(ap) genentech inc.'s third-quarter profit fell rose 6.7 percent on sales of key cancer drugs, the biotechnology company said tuesday, matching wall street's profit forecasts. the results mark another quarter where the biotech giant either met or ...
www.cbsnews.com

Rituxan Plus Chemotherapy Effective For Leukemia Treatment - Emaxhealth.com
rituxan is found to be a good blood cancer treatment method given together with traditional chemotherapy. genentech inc. and biogen idec conducted a late stage trial called reach and involving 552 chronic lymphocytic leukemia patients, who had ...
www.emaxhealth.com

Genentech's 3rd-quarter Profit Rises 6.7 Percent On Cancer Treatment Sales, Meets Forecasts
new york - genentech inc.'s third-quarter profit rose 6.7 percent on rising sales of key cancer drugs, the biotechnology company said tuesday, matching wall street's profit forecasts.
www.startribune.com

Genentech's 3rd-quarter Profit Rises 6.7 Percent On Cancer Treatment Sales, Meets Forecasts
new york - genentech inc.'s third-quarter profit fell rose 6.7 percent on sales of key cancer drugs, the biotechnology company said tuesday, matching wall street's profit forecasts.
www.startribune.com

Call For New Standards Of Care In Arthritis/rheumatism - Genetic Engineering News
12 october 2008 an online survey for world arthritis day (wad), completed by over 3,600* respondents revealed that access to psychological support and self-management courses could help people with arthritis/rheumatism cope more effectively with ...
www.genengnews.com

New Fears Over Safety Of Arthritis Drug - Yorkshirepost
new research has confirmed a drug taken by millions worldwide to relieve pain from arthritis "substantially" increased their risk of stroke, heart attack and death. the study published today found patients taking vioxx for three years faced double ...
www.yorkshirepost.co.uk

Csu To Study Herbal Supplements For Arthritic Dogs
a new colorado state university study will see whether the same herbal supplements people are taking to soothe their aches and pains can do the same for dogs suffering from arthritis.
www.denverpost.com

Health Calendar 10/14/08
todayn arthritis and fibromyalgia education series: 6:30 p.m. at the saint francis health and wellness conference room 1. program on inflammatory arthritis. to register, call 331-5880 or 888-216-3293.n the facts about prostate cancer: 6:30 to 8 p.m.
www.semissourian.com

Biogen Withdraws Arthritis Drug After Trial Failures - Mass High Tech
cambridge biotech biogen idec has stopped the development of its rheumatoid arthritis drug, baminercept, after it failed to meet both its primary and secondary endpoints in a phase 2 trial, company officials announced. the drug was intended to treat ...
www.masshightech.com